Newsflash:
- Lilly Ends Alzheimer's Drug Study on Safety Concern
- Osteoporosis Drug Xgeva Approved by FDA to Treat Giant Cell Bone Tumors
- High Prevalence of NSAID Prescription in Those at Risk of Heart Attack/Death in Primary Care
- Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data From Phase 2 Open-Label Study of Investigational Agent Elotuzumab
- Updated Results of Two Phase 2 Ibrutinib Studies in Patients With Mantle Cell Lymphoma or Diffuse Large B-cell Lymphoma
- New Long-Term Data Reinforce Safety Profile of Pradaxa for Stroke Prevention in AF
Drug Shortages Update - June 5, 2012
- Drug Shortages: Current Drug Shortages: Atropine Sulfate Injection (updated)
- Drug Shortages: Current Drug Shortages: Digoxin Injection (updated)
- Drug Shortages: Current Drug Shortages: Diltiazem Injection (updated)
- Drug Shortages: Current Drug Shortages: Diphenhydramine Hydrochloride Injection (updated)
- Drug Shortages: Current Drug Shortages: Hydromorphone Hydrochloride Injection (updated)
- Drug Shortages: Current Drug Shortages: Morphine Sulfate Injection (Preservative Free) (updated)
- Drug Shortages: Current Drug Shortages: Ondansetron Injection 2 mg/mL (updated)
- Drug Shortages: Current Drug Shortages: Sufentanil Injection (updated)
Sponsor Highlights
Our Sponsors:
Sitemap
© Pharmacist e-Link
